Travere Therapeutics (TVTX) Payables (2011 - 2026)
Travere Therapeutics' Payables was $7.5 million in Q2 2026, down 60.8% from $19.13 million a year earlier and down 42.0% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Payables (2011 - 2026) Analysis & Trends
At the end of FY2025, Payables at Travere Therapeutics came in at $24.8 million, up 5.4% from FY2024.
- Payables shows a five-year compound annual growth rate of 15.4% (FY2020 to FY2025).
- In earlier years, Payables was $23.53 million in FY2024 (-43.5%), $41.68 million in FY2023 (+141.0%), $17.29 million in FY2022 (+14.2%) and $15.14 million in FY2021 (+24.8%).
- The Q2 2026 figure marks the lowest quarterly Payables since Q3 2021.
- Compared with a year earlier, Payables was higher in 1 of the last eight quarters, with an average decline of 22.1%.
- The best year-over-year quarter for Payables over five years was Q4 2023 (growth of 141.0%); the worst was Q2 2026 (a decline of 60.8%).
- Per Business Quant data, TVTX's Payables in the three quarters before Q2 2026 was $12.91 million (Q1 2026), $24.8 million (Q4 2025) and $18.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Travere Therapeutics | 5.80 Bn | 5.40 Bn | 167.41 Mn | 7.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.50 Mn |
| Mar 31, 2026 | 12.91 Mn |
| Dec 31, 2025 | 24.80 Mn |
| Sep 30, 2025 | 18.23 Mn |
| Jun 30, 2025 | 19.13 Mn |
| Mar 31, 2025 | 15.37 Mn |
| Dec 31, 2024 | 23.53 Mn |
| Sep 30, 2024 | 23.20 Mn |
| Jun 30, 2024 | 25.84 Mn |
| Mar 31, 2024 | 16.73 Mn |
| Dec 31, 2023 | 41.68 Mn |
| Sep 30, 2023 | 24.74 Mn |
| Jun 30, 2023 | 19.92 Mn |
| Mar 31, 2023 | 16.73 Mn |
| Dec 31, 2022 | 17.29 Mn |
| Sep 30, 2022 | 14.01 Mn |
| Jun 30, 2022 | 11.85 Mn |
| Mar 31, 2022 | 18.43 Mn |
| Dec 31, 2021 | 15.14 Mn |
| Sep 30, 2021 | 5.83 Mn |
API Access
Travere Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();